Research ArticleNanomedicine

Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo

See allHide authors and affiliations

Science Translational Medicine  10 Feb 2016:
Vol. 8, Issue 325, pp. 325ra17
DOI: 10.1126/scitranslmed.aad2355

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article